A physician in Slidell, La., has been charged in connection with an alleged $6.6 million fraud scheme.
Between February and September 2019, Robert Tassin, MD, allegedly signed physician orders for genetic cancer screening tests through purported telemedicine companies for Medicare beneficiaries he never saw, spoke to or treated, according to a March 12 news release from the Justice Department.
Dr. Tassin’s orders reportedly led to more than $6.6 million in false and fraudulent claims submitted to Medicare, resulting in over $2 million in reimbursements.
Prosecutors allege that Dr. Tassin made multiple fraudulent statements to support these orders, including falsely certifying in medical records that the CGx tests were medically necessary for patient treatment.
In return for electronically reviewing patient charts and ordering CGx tests, Dr. Tassin was allegedly paid a set fee per order, totaling $106,757.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.